NovaBay Pharmaceuticals Statistics
Total Valuation
NBY has a market cap or net worth of $2.16 million. The enterprise value is $2.76 million.
| Market Cap | 2.16M |
| Enterprise Value | 2.76M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NBY has 1.08 million shares outstanding. The number of shares has increased by 1,112.38% in one year.
| Shares Outstanding | 1.08M |
| Shares Change (YoY) | +1,112.38% |
| Shares Change (QoQ) | +485.34% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 0.92% |
| Float | 1.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.15 |
| Forward PS | 0.13 |
| PB Ratio | 13.51 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.92, with a Debt / Equity ratio of 15.14.
| Current Ratio | 0.92 |
| Quick Ratio | 0.65 |
| Debt / Equity | 15.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -389.10% and return on invested capital (ROIC) is -287.77%.
| Return on Equity (ROE) | -389.10% |
| Return on Assets (ROA) | -171.60% |
| Return on Capital (ROIC) | -287.77% |
| Revenue Per Employee | $547,423 |
| Profits Per Employee | -$713,538 |
| Employee Count | 26 |
| Asset Turnover | 1.32 |
| Inventory Turnover | 2.91 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.35% in the last 52 weeks. The beta is 0.83, so NBY's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -92.35% |
| 50-Day Moving Average | 2.97 |
| 200-Day Moving Average | 6.29 |
| Relative Strength Index (RSI) | 38.46 |
| Average Volume (20 Days) | 91,708 |
Short Selling Information
The latest short interest is 74,732, so 6.91% of the outstanding shares have been sold short.
| Short Interest | 74,732 |
| Short Previous Month | 647,573 |
| Short % of Shares Out | 6.91% |
| Short % of Float | 6.94% |
| Short Ratio (days to cover) | 0.30 |
Income Statement
In the last 12 months, NBY had revenue of $14.23 million and -$18.55 million in losses. Loss per share was -$121.80.
| Revenue | 14.23M |
| Gross Profit | 7.75M |
| Operating Income | -7.43M |
| Pretax Income | -11.12M |
| Net Income | -18.55M |
| EBITDA | -10.95M |
| EBIT | -11.12M |
| Loss Per Share | -$121.80 |
Balance Sheet
The company has $1.82 million in cash and $2.42 million in debt, giving a net cash position of -$600,000 or -$0.56 per share.
| Cash & Cash Equivalents | 1.82M |
| Total Debt | 2.42M |
| Net Cash | -600,000 |
| Net Cash Per Share | -$0.56 |
| Equity (Book Value) | 160,000 |
| Book Value Per Share | 0.15 |
| Working Capital | -333,000 |
Cash Flow
In the last 12 months, operating cash flow was -$4.09 million and capital expenditures -$8,000, giving a free cash flow of -$4.10 million.
| Operating Cash Flow | -4.09M |
| Capital Expenditures | -8,000 |
| Free Cash Flow | -4.10M |
| FCF Per Share | -$5.82 |
Margins
Gross margin is 54.47%, with operating and profit margins of -52.22% and -130.34%.
| Gross Margin | 54.47% |
| Operating Margin | -52.22% |
| Pretax Margin | -78.09% |
| Profit Margin | -130.34% |
| EBITDA Margin | -76.94% |
| EBIT Margin | -78.09% |
| FCF Margin | -28.81% |
Dividends & Yields
NBY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,112.38% |
| Shareholder Yield | -1,112.38% |
| Earnings Yield | -858.17% |
| FCF Yield | -189.66% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 31, 2024. It was a reverse split with a ratio of 1:35.
| Last Split Date | May 31, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:35 |
Scores
NBY has an Altman Z-Score of -50.65 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -50.65 |
| Piotroski F-Score | 3 |